Utah Medical Products, Inc. (NASDAQ:UTMD) to Issue $0.31 Quarterly Dividend

Key Points

• Utah Medical Products, Inc. has declared a quarterly dividend of $0.31 per share, which is set to be paid on October 2nd, representing an annualized dividend of $1.22 and a yield of 2.16%.
• The company's stock is currently down 0.1%, trading at $56.38, with a market capitalization of $183.24 million and a P/E ratio of 15.07.
• Institutional investors own 69.60% of Utah Medical Products, with Jane Street Group recently acquiring a new stake valued at approximately $317,000.

Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) declared a quarterly dividend on Wednesday, July 30th, Wall Street Journal reports. Stockholders of record on Wednesday, September 17th will be given a dividend of 0.305 per share by the medical instruments supplier on Thursday, October 2nd. This represents a c) annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Wednesday, September 17th.

Utah Medical Products Price Performance

NASDAQ UTMD traded down $0.65 during mid-day trading on Friday, reaching $54.95. 14,304 shares of the stock were exchanged, compared to its average volume of 13,457. Utah Medical Products has a one year low of $51.26 and a one year high of $69.30. The stock has a 50 day simple moving average of $56.15 and a 200-day simple moving average of $56.75. The stock has a market cap of $178.59 million, a P/E ratio of 14.69 and a beta of 0.31.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter. The firm had revenue of $9.95 million during the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.50%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Bessemer Group Inc. bought a new position in shares of Utah Medical Products in the fourth quarter worth $31,000. Tower Research Capital LLC TRC increased its holdings in shares of Utah Medical Products by 172.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock worth $32,000 after purchasing an additional 328 shares during the period. Deutsche Bank AG purchased a new position in Utah Medical Products in the 4th quarter worth approximately $43,000. CWM LLC grew its stake in Utah Medical Products by 287.4% in the 2nd quarter. CWM LLC now owns 829 shares of the medical instruments supplier's stock worth $47,000 after buying an additional 615 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its stake in Utah Medical Products by 156.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock worth $50,000 after buying an additional 546 shares in the last quarter. 69.60% of the stock is owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.